Taro Pharmaceutical Industries, a multinational, science-based pharmaceutical company, has received a new patent covering its Ovide lotion, 0.5% from the US Patent and Trademark Office.
The patent is for a highly pure form of Ovide (malathion) for topical pharmaceutical use and a method of making pure pharmaceutical grade malathion, as well as for a formulation containing the pharmaceutical grade malathion and a method for treating head lice.
No comments:
Post a Comment